Risks of cardiovascular disease and second malignancy after treatment for Hodgkin lymphoma - Flora E. van Leeuwen, PhD, MSc

DCEG Events

May 21, 2015 | 1:00 AM – 2:00 AM

NCI Shady Grove

Add to Outlook Calendar

Speaker: Flora E. van Leeuwen, Ph.D., M.Sc.
Professor and Chair in Cancer Epidemiology, EMGO Institute, Faculty of Medicine, Vrije Universiteit, Amsterdam and
Head, Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam

Title:  Risks of cardiovascular disease and second malignancy after treatment for Hodgkin lymphoma

Description:  Hodgkin lymphoma survivors are a critical population for studying late effects of cancer treatments because of their good prognosis, relatively young age at diagnosis, and frequent receipt of radiotherapy and systemic therapy.  This seminar will provide novel data on changes in risk of cardiovascular disease and second malignancies based on changes in Hodgkin lymphoma treatments over time. Recent study results promise to provide mechanistic insights as well as having direct translational impact.